| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Correction to Lancet Haematol 2017; 4: e431–42
|
|
|
2018
|
5 |
8 |
p. e332
|
artikel
|
| 2 |
Correction to Lancet Haematol 2018; 5: e289–98
|
|
|
2018
|
5 |
8 |
p. e332
|
artikel
|
| 3 |
Correction to Lancet Haematol 2018; 5: e273–74
|
|
|
2018
|
5 |
8 |
p. e332
|
artikel
|
| 4 |
Genes expressed in red cells could shape a malaria attack
|
Luzzatto, Lucio
|
|
2018
|
5 |
8 |
p. e322-e323
|
artikel
|
| 5 |
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study
|
Ndila, Carolyne M
|
|
2018
|
5 |
8 |
p. e333-e345
|
artikel
|
| 6 |
Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies
|
Little, Mark P
|
|
2018
|
5 |
8 |
p. e346-e358
|
artikel
|
| 7 |
Leukaemia risk associated with low-dose radiation
|
Hourigan, Christopher S
|
|
2018
|
5 |
8 |
p. e324-e325
|
artikel
|
| 8 |
23rd European Hematology Association Congress
|
Smith, Lan-Lan
|
|
2018
|
5 |
8 |
p. e330-e331
|
artikel
|
| 9 |
Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden
|
Chattopadhyay, Subhayan
|
|
2018
|
5 |
8 |
p. e368-e377
|
artikel
|
| 10 |
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
|
Federico, Massimo
|
|
2018
|
5 |
8 |
p. e359-e367
|
artikel
|
| 11 |
Rituximab as a first step in tackling transformation
|
Okosun, Jessica
|
|
2018
|
5 |
8 |
p. e326-e327
|
artikel
|
| 12 |
Secondary primary cancers before and after myeloid neoplasia: a two-way street
|
Garcia-Manero, Guillermo
|
|
2018
|
5 |
8 |
p. e328-e329
|
artikel
|
| 13 |
The FDA's definitions, designations, and drug approvals: too daring?
|
The Lancet Haematology,
|
|
2018
|
5 |
8 |
p. e321
|
artikel
|
Tijdschrift beschrijving